Clinical Trial Update: Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an unspecified dopamine agonist for hemispatial neglect and motor deficits following right-hemisphere stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemispatial Neglect
• Stroke

Drugs mentioned

• Dopamine agonist (unspecified)

Snippet

Sponsor: University College, London | Conditions: Right Hemisphere Stroke, Hemispatial Neglect | Phase 2 | Status: COMPLETED